BioNano Genomics
Presence
BioNano Genomics is a company listed under the stock ticker BNGO (US).
Executives
View the org chart displaying its 28 main executives
Most searched biographies at BioNano Genomics
- Erik Holmlin, Director, President and Chief Executive Officer
- Kristiina Vuori, Director
- David Barker, Chairman of the Board
Popular executive movements at BioNano Genomics
- Christopher Stewart, Chief Financial Officer, will retire in Sep. 2023 (posted on August 15 2023).
- Gülsen Kama has joined the company as Chief Financial Officer (posted on August 15 2023).
Create your alert
to follow the executive moves at BioNano Genomics.
Biotechnology
BioNano Genomics has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Karius has just announced a $100 Million fundraising (posted on May 3 2024).
- Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
- WindRose Health Investors has announced the acquisition of SubjectWell (posted on May 2 2024).
Popular contacts in Biotechnology
News
Press releases by BioNano Genomics
- Bionano Announces Presentation of OGM Utility Across Key Research Applications at the Association for Molecular Pathology Annual Meeting | Bionano Genomics, Inc.
- Bionano Reports Third Quarter 2023 Results and Highlights Recent Business Progress | Bionano Genomics, Inc.
- Bionano Announces Presentation of OGM Utility Across Key Applications at the American Society of Human Genetics (ASHG) Annual Meeting | Bionano Genomics, Inc.
- Bionano to Report Third Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 8, 2023 | Bionano Genomics, Inc.
- Thompson and Thompson Genetics and Genomics in Medicine Includes OGM in Latest Edition, Notes Workflow’s Performance and Ability to Detect More SVs than LRS at Lower Cost | Bionano Genomics, Inc.
- Bionano to Present at the 2023 Stifel Healthcare Conference | Bionano Genomics, Inc.
- Largest Study of Mendelian Disease Highlights how OGM, alongside other Techniques, May Enhance Success Rates in Identifying Molecular Causes of Genetic Disease | Bionano Genomics, Inc.
- Bionano Announces Peer-Reviewed Publication on the Utility of Combining OGM and WES for Evaluation of Pediatric Leukemia | Bionano Genomics, Inc.
- Bionano Announces Publication Demonstrating Utility of OGM as an Alternative to KT and CMA for Evaluating CRISPR-Edited Cells as Part of Stem Cell Therapy Development | Bionano Genomics, Inc.
- Bionano Announces Second OEM Partner has Received China NMPA Approval for DNA Extraction and Labeling Products for IVD Use of OGM in Reproductive Health | Bionano Genomics, Inc.
- View more press releases Close
Social media about BioNano Genomics
- BioNano Genomics on Wikipedia, Google News & Yahoo Finance
- BioNano Genomics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Erik Holmlin 
Call BioNano Genomics at +1 858...
